Xheme, Inc.
Biotechnology · Bioprocessing
$125ktotal raised · 7 rounds on record
$40klatest round · Venture round · Sep 2025 · 13 mo ago
$1Mrevenue · 2024 · SEC Form D 0001827457-25-000002
$1.7Mgrants · 3 grants · CORDIS
Overview
About Us Meet The Team The Xheme team is made up of materials scientists, engineers, cell biologists, organic chemists, and entrepreneurs. We're a team with an audacious vision: a world in which technology benefits manufacturers, consumers, and the environment.
Funding and backers
Total raised
$125k
7 rounds on record
Latest round
$40k
Venture round · Sep 2025 · 13 mo ago
Team
1-10
employees, estimated range
Grants
$1.7M
3 grants · CORDIS
Revenue
$1M
2024 · SEC Form D 0001827457-25-000002
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1, 2025
Won a grant $1.2M · CORDIS
Feb 7, 2024
Partnership Xheme and Vitalant Research Institute collaborate on new non-toxic, non-PVC blood bag technology · xhemeinc.com
Jan 15, 2024
Won a grant $275k · CORDIS
Oct 16, 2023
Raised a round Venture round $50k · SEC Form D
Apr 4, 2022
Raised a round Venture round $10k · SEC Form D
Jul 1, 2021
Won a grant $256k · CORDIS
Sep 27, 2020
Raised a round Venture round $25k · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2025 | $40k | — | SEC Form D |
| Grant | Sep 2025 | $1.2M | — | CORDIS |
| Grant | Jan 2024 | $275k | — | CORDIS |
| Venture round | Oct 2023 | $50k | — | SEC Form D |
| Venture round | Apr 2022 | $10k | — | SEC Form D |
| Grant | Jul 2021 | $256k | — | CORDIS |
| Venture round | Sep 2020 | $25k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Xheme Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kumar ChallaExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Bioprocessdevelopmentin IndustrialBiotechnology. Biotrend is a research-based company specialized in the development, optimization and…
Patented ELAREM™ cell culture supplements: Human Platelet Lysate (HPL) xeno-free NEW: Artificial HPL PL BioScience.
300MICRONS GmbH is an SME seated in Karlsruhe, Germany, that develop, manufactures and markets flexible 3D cell culture solutions and…
Intelligent robotics for cell culture automation. Whelix combines AI agents with lab robotics so your biology runs 24/7 — protocols…
Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable…
CAVIGEN GmbH Home CaviSphere MicroSphere PoroSphere SensoSphere Customized Solutions Knowledge Hub About Us About CAVIGEN CAVIGEN is a…
Financials
Est. Annual Revenue
$500k
2024
Total raised
$1.8M
Latest round
Venture - Series Unknown
Funding rounds
7
People
Kumar Challa
Executive Officer, Director
Nambula Venugopal
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Xheme, Inc.
Xheme, Inc. is a specialty materials company based in Newton, MA, working to revolutionize bioplastic, coating, and film manufacturing by eliminating the need for single-use/single-function additives through the use of one multifunctional additive that pr
Read more
Report
Testing Xheme Materials in the Space Environment
Modern materials are increasingly expected to perform under extreme conditions, whether in bioprocessing systems on Earth or in space infrastructure. Xheme develops advanced polymer films enhanced with proprietary nano-additives designed to resist oxidati
Read more
Report
Xheme Inc. Demonstrates Breakthrough in Bioprocessing Innovation, Driving Higher Cell Density and Biologics Yields
Links https://markets.businessinsider.com/news/stocks/xheme-inc-demonstrates-breakthrough-in-bioprocessing-innovation-driving-higher-cell-density-and-biologics-yields-1035746218 https://finance.yahoo.com/news/xheme-inc-demonstrates-breakthrough-bioprocess
Read more
Report
Xheme Inc. Demonstrates Breakthrough in Bioprocessing Innovation, Driving Higher Cell Density and Biologics Yields
NEWTON, MA / ACCESS Newswire / January 26, 2026 /Xheme Inc., a biopharmaceutical innovator developing advanced technologies for life sciences manufacturing, today announced a breakthrough that could redefine how biological cells are produced and stored. .
Read more
Report
Exciting IP milestone for Xheme Inc
We've received Notices of Allowance for critical claims across three US Patents-each representing a key pillar of our innovation strategy: Technology licensed from VCOM for blood storage (U.S. Patent No. 17/263,526) Xheme's proprietary multifunctional add
Read more
Report
We've secured $1.2M NSF-STTR Phase II grant
Big news from Xheme Inc: We've just secured our fourth federal award-a $1.2M NSF-STTR Phase II grant-to scale up our non-toxic blood bag technology in collaboration with Vitalant Research Institute (VRI). This milestone builds on our previous NSF and NASA
Read more
Report
Xheme Project Selected for Spaceflight Mission to Evaluate Recyclable Plastics that Protect Biomedical Fluids and Food Against Space Radiation
Newton, MA - Xheme Inc. ("Xheme"), a leading materials science company, announced today that the Center for the Advancement of Science in Space, Inc., manager of the International Space Station (ISS) National Laboratory, has awarded a spaceflight opportun
Read more
Report
The Science Times Covers Xheme's Breakthrough in Human Milk Storage Technology
Newton, MA - December 03, 2024 - Xheme Inc., in partnership with Dr. Shannon Kelleher of UMass Lowell, is making strides in human milk storage with their innovative, eco-friendly, non-toxic film technology designed to combat oxidative stress. This groundb
Read more
Report
Xheme Presents Cutting-Edge Human Milk Preservation Technology at International Symposium in Bologna
Bologna, Italy - July 8-10, 2024 - Xheme's technology for enhancing the shelf-life and nutritional quality of human milk was presented at the 5th International Symposium on Lipid Oxidation and Antioxidants in Bologna, Italy. Click here for more informatio
Read more
Report
Xheme and Vitalant Research Institute collaborate on new non-toxic, non-PVC blood bag technology
Boston-area specialty materials company, Xheme, Inc., and leading transfusion medicine research institute, Vitalant Research Institute (part of Vitalant, one of the nation's largest nonprofit blood and biotherapies healthcare organizations), collaborate o
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Newton
United States
HQ
1-10 est. staff